About
Research
Patient Care
Education & Training
Community
Jun 22, 2023
Breakthroughs offer hope for vitiligo patients
In 2018, Dr. Anand K. Ganesan (above left) opened a vitiligo specialty practice lab at the UCI Health Beckman Laser Institute & Medical Clinic, hoping to find new therapies to reverse the disfiguring skin disorder. Now, the lab has produced a topical cream called ruxolitinib, the first therapy approved by the U.S. Federal Drug Administration that restores pigment in vitiligo patients. The FDA also recently gave breakthrough device approval for RECELL®, a one-time therapy using the patient’s healthy cells to stimulate lasting repigmentation in stable vitiligo.
Jun 21, 2023
Cancer researchers learn about big data analysis using Anvil
The BigCare workshop, otherwise known as the “Big Data Training for Cancer Research,” is a program funded by the National Cancer Institute (NCI). The purpose of the workshop is to help cancer researchers develop the requisite skills for managing, visualizing, analyzing, and integrating various types of “omics” data in cancer studies. BigCare was founded in 2020 by Min Zhang, PhD, a professor of epidemiology and biostatistics at the University of California, Irvine’s Program in Public Health, as well as the biostatistics shared resources director for the UCI Chao Family Comprehensive Cancer Center.
Jun 20, 2023
FDA Approves New Drug Combo For Prostate Cancer
Alexandre Chan, PharmD, MPH, professor of clinical pharmacy at the School of Pharmacy & Pharmaceutical Sciences at University of California, Irvine is similarly excited about the prospect of this combination of medications being better understood and implemented. “I think that’s good news for patients, in the sense that there are additional therapies that we can use at first line and [they] have demonstrated that if you have the proper mutations, you get much better progression free and also overall survival.”
Jun 14, 2023
Adjusting Your Body Clock May Stave Off Cancer
For some time now epidemiological studies of night-shift workers have linked disruptions in circadian rhythms to cancer and other diseases. … “We're starting to understand the reasons these things happen,” says Selma Masri, a circadian biologist and assistant professor at the University of California, Irvine, who has shown how circadian disruption pushes colon cancer progression by interfering with the way certain genes are expressed.
Jun 09, 2023
Rise in colorectal cancer among young adults an alarming trend
The rise in colon cancer rates among millennials has been alarming. "Physicians are aware, primary care doctors are aware, oncologists are aware, and I am not sure the public is aware that it is a real issue," said Dr. Jason Zell, at UCI Health Chao Family Comprehensive Cancer Center and UCI associate professor.
Jun 08, 2023
UC Irvine study finds that lesbian, gay and bisexual cancer survivors experience more health-related challenges compared to heterosexual counterparts
Public health researchers from the University of California, Irvine have determined that lesbian, gay and bisexual cancer survivors experience a lower quality of life compared to their heterosexual counterparts, specifically in the mental and social aspects of their overall health. Corresponding author Michael Hoyt, PhD, associate professor of population health and disease prevention from UCI’s Program in Public Health, and his collaborators published their findings in the Journal of Psychosocial Oncology.
Jun 06, 2023
Jung In Park, University of California, Irvine – Survival Machine Learning for Breast Cancer Patients
Racial disparities can exist even in machine learning. Jung In Park, assistant professor in the Sue & Bill Gross School of Nursing at the University of California, Irvine, finds a way to tackle biases and make a difference for vulnerable populations
May 30, 2023
Courageous Corazones
A pilot intervention is helping Latinx families care for their children with cancer. Corazones Unidos Por Una Vida (Hearts United for Life) is a prototype program of support for Latinx families with children who are undergoing cancer treatment at Children’s Hospital of Orange County. It is designed and driven by Associate Professor Michelle Fortier, a clinical psychologist and pediatric pain expert at the Sue & Bill Gross School of Nursing and UCI Center on Stress and Health. Fortier is also a CFCCC member.
May 25, 2023
Celebrating decades long UC Irvine legacy and impact on cancer research & public health interventions
Professor of population health and disease prevention and general internal medicine – Lari Wenzel, PhD, from the UCI Program in Public Health and the School of Medicine, is retiring at the end of June after 27 years of campus service. She leaves an outstanding legacy of achievements and a portfolio of valuable cancer research. Her contributions to the public health field are truly remarkable and her impact on countless students, faculty, and communities around the nation cannot be overstated.
May 02, 2023
Cancer Control Members receive School of Medicine New Investigator Faculty Research Grant
Drs. Jacqueline Kim, Sunmin Lee, and Edward Kuan, Cancer Control Members, receive School of Medicine New Investigator Faculty Research Grant. The overall goal of this funding mechanism is to help early-stage investigators in the School of Medicine obtain extramural funding and to promote collaborative interdisciplinary research.